Fortuno For the third and hopefully last time I will

New Post Public Reply Private Reply Replies (1) Message Board
sunclouds Fortuno #36566
732
Fortuno
For the third and hopefully last time I will explain to you why I don't think that warrant holders selling is significant. See my responses supported by actual data to your post:

QUOTE

You're asking me to prove something that just can't be proved.

What we do know is that the share price hasn't gone up while the number of outstanding shares is increasing due to warrant excersises.
There has been (and still is) increased demand for the shares, that's noticable because there have been a lot of new names showing up on this board.
Someone is supplying all that new demand.


I am shocked that someone would measure the demand for shares based upon the amount of new names showing up on a message board. You post which is ¾ of a day old now has 300 views – not a great indicator in my mind.

Luckily for you I have pulled together some data that really demonstrates investor interest in a stock – daily trading volume. The data disproves your theory that there is increased demand for shares (which is the first of the many wrong assertions that you make)

The average daily volume over the last two months is as follows:
April: 213M shares traded over 21 days for an avg of 10.1 Million shares a day
May: 101M shares traded over 20 days for avg of 5.07 million shares per day
June 10.5 million shares traded over 4 days for an avg of 2.63 million shares per day

This disproves with data that there is increasing demand for the stock lately.

QUOTE

I don't share your view on the tax implications of selling shares as one can chose which shares have been sold. Obviously one would pick the older lots with a 20% tax rate.
Now even your own commenst contradicts your proposition. If you sold older lots, then you would not be selling warrants that you exercised recently since the 20% tax rate applies to warrants held for a year

The selling of warrantholders isn't ubstantiated it makes very much sense.


Again, your comment without any data is easily disproven. If you just look at sales for the last two months, over 300million shares were sold. Even if you assume only 50% of the sales are from warrant holders, they would have had to sell over 150Million shares in just two months. Unless they are selling to other warrant holders, these size of sales would exhaust shares held by warrant holders especially if you extend the analysis for the many months you have been claiming that this situation existed. Either you were wrong before or there can’t be any shares left for warrant holders to sell from their accounts. You can’t have it both ways so were you wrong before or is this problem one that no longer exists?

QUOTE

I'm thinking of derisking, but also profit taking and warrant holders that would like to exercise but lack funds to do so or don't want to increase the liquidity put into Cydy (as the exercise price has to be paid).


People who didn’t want to increase their liquidity into CYDY simply would let their options sit unexercised since they likely have years left until they expire. If in fact they did exercise their warrants, it would actually be good for the company since exercising warrants brings in cash to the company which we desperately need. Now that there are significant gains, the smart person who exercises a warrant would hold for a year to save 17% on their tax bill (37% to 20%)


QUOTE

What is it according to you that keeps the share price from going up?
And could you provide any proof?
Cheers!

My conclusion based upon all of the facts that I provided is that warrant holders selling is not causing the stock price to be held which I believe is the assertion that you keep making.

To better support you position you should look back a year as to when warrants were executed to see the timeframe in which those help in taxable accounts might be sold which would of course depend on whether the holder thought there was a price inflection point coming in the near term in which case they still might hold a bit longer.

I await your proof and supporting data why you still think that warrant holder selling is a major factor in holding down the stock price.

IMO
Cheers,
Sunclouds


1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 3

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 3

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 2

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 2

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 2

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 2

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 4

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading

Top 5 Most Recently Viewed Articles

Compass Therapeutics Pursues Growth with New Public Offering

Updated Category News Views 134

Compass Therapeutics Initiates Public Offering Compass Therapeutics, Inc. (NASDAQ: CMPX), a dynamic and innovative biopharmaceutical company at the forefront of developing antibody-based therapies for cancer treatment, has announced the initiation of an underwritten public offering. This move aims to bolster its financial foundation to facilitate the advancement of its...

Continue Reading
Whirlpool Corporation Declares Substantial Quarterly Dividend

Updated Category News Views 312

Whirlpool Corporation Announces Quarterly Dividend Today, the board of directors of Whirlpool Corporation has declared a quarterly dividend of $1.75 per share on the Company's common stock. This dividend showcases the company's commitment to returning value to its shareholders. It will be payable on June 15, 2025, to stockholders of record at the close of business on May...

Continue Reading
How Tastytrade and Zerohash Transformed Account Funding

Updated Category News Views 312

Tastytrade Enables Instant Stablecoin Funding for Traders Tastytrade, the innovative online brokerage firm designed specifically for self-directed investors, has taken a significant leap forward in enhancing the trading experience. By partnering with Zerohash, they have rolled out an advanced stablecoin account funding option. This cutting-edge method allows traders...

Continue Reading
AKVA Group ASA's Strategic Buyback Program for Shares

Updated Category News Views 155

AKVA Group ASA Initiates Share Buyback Program In a recent announcement, AKVA Group ASA has taken a significant step towards enhancing its shareholder value by initiating a buyback program for up to 60,000 of its own shares. This strategic move is part of the company's plan to reinvest in its workforce through an employee share program, thereby fostering a stronger...

Continue Reading
Nvidia Stock: A Buying Opportunity Amid Market Fluctuations

Updated Category News Views 125

Nvidia Stock Sees Pre-Market Decline Shares of Nvidia Corporation (NASDAQ: NVDA) experienced a decline of 2.01% during the pre-market trading session. This drop followed the company's announcement that it had no revenue from H20 chip sales in China. This news has created some concerns among investors, although industry analysts see potential in the current situation....

Continue Reading